comparemela.com
  1. Home
  2. Live Updates
  3. Slamon Research Laboratory - Breaking News

Latest Breaking News On - Slamon research laboratory - Page 1 : comparemela.com

TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline

$158M Series B-2 Financing led by Deep Track Capital, with new participation from leading global biotechnology investors including RA Capital Management,.

Dave licataVince ruizRibociclib kisqaliMark allesPalbociclib ibranceDennis slamonPerceptive xontogeny venture fundSlamon research laboratoryBristol myers squibbDivision of hematology oncologyRoth zabelCrandon lawDavid geffen school of medicineDeep track capitalPerceptive advisorsAvidity partners

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.